International Agencies

This website contains general information about TB, TB guidelines, and country specific documents that are found on TB CAP's Toolbox CD ROM.

This new report on anti-tuberculosis (TB) drug resistance by the World Health Organization (WHO) updates “Anti-tuberculosis drug resistance in the world: Report No. 4” published by WHO in 2008. It summarizes the latest data and provides latest estimates of the global epidemic of multidrug and extensively drug-resistant tuberculosis (M/XDR-TB). For the first time, this report includes an assessment of the progress countries are making to diagnose and treat MDR-TB cases.

This is the seventeenth global report on tuberculosis (TB) published by WHO in a series that started in 1997. It provides a comprehensive and up-to-date assessment of the TB epidemic and progress in implementing and financing TB prevention, care and control at global, regional and country levels using data reported by 204 countries and territories that account for over 99% of the world’s TB cases.

This fact sheet describes the burden of TB in women, the impact of TB on maternal health, and what can be done.

This field guide is meant to serve as a tool for practitioners working with children at risk of infection or being sick with MDR TB. It should be considered complementary to existing recommendations.

This infographic provides an overview of the global TB epidemic.

This guideline sets forth the framework to guide European countries in developing their national plan for reducing TB/HIV morbidity and mortality. The framework sets out the rationale for effective collaboration between HIV/AIDS and tuberculosis national programs.

This series of four fact sheets provides information on DOTS including advocacy planning.

This booklet explains the action and resources needed over the next five years for six working groups to expand, adapt, and improve DOTS, enabling the working groups to meet the 2005 global targets of setting the world on the road to the elimination of TB.

These guidelines offer recommendations for TB control programmes and medical workers in middle- and low- income countries faced with drug-resistant forms of TB, especially MDR-TB.